Mahindra & Mahindra Other Announcement
The company filed its quarterly shareholding pattern for the period ending September 30, 2026. This periodic compliance disclosure provides details on promoter and public shareholding.
ALFA Filings
Every announcement, straight from the exchange
Every Mahindra & Mahindra other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
8 announcements with these filters
The company filed its quarterly shareholding pattern for the period ending September 30, 2026. This periodic compliance disclosure provides details on promoter and public shareholding.
Dr. Anish Shah, Group CEO and MD, sold 76,357 equity shares to fund tax liabilities from ESOP exercises. This is a routine personal transaction disclosure.
Mahindra & Mahindra Ltd. received an independent ESG rating of 71 from NSE Sustainability Ratings & Analytics Limited, without having engaged them for the service.
Mahindra & Mahindra received ESG ratings from CRISIL (72) and ESG Risk Assessments & Insights (67). These assessments reflect the company's strong ESG performance.
Mahindra & Mahindra has filed its quarterly shareholding pattern for the period ending June 30, 2026. The report provides a standard breakdown of promoter and public shareholding.
Mahindra & Mahindra cancelled its participation in the Morgan Stanley India Investment Forum 2026. The meeting was originally scheduled for June 2, 2026, in Mumbai.
Mahindra & Mahindra Ltd has submitted its mandatory disclosure of Related Party Transactions for the half-year ended March 31, 2026. The report, filed under SEBI Regulation 23(9), details various transactions including sales, purchases, and inter-corporate deposits with subsidiaries and associates during the period.
Mahindra & Mahindra Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by M/s. Parikh & Associates, confirms the company's general compliance with SEBI regulations and listing requirements during the review period.